PA
ASAN icon

PharVision Advisers’s Asana ASAN Stock Holding History

PharVision Advisers’s Portfolio ASAN Stock Details ASAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$120K Sell
18,741
-30,450
-62% -$268K 1.22% 33
2025
Q4 		$674K Buy
49,191
+32,877
+202% +$452K 0.34% 4
2025
Q3 		$218K Buy
16,314
+6,191
+61% +$87.5K 0.12% 440
2025
Q2 		$137K Buy
+10,123
New +$159K 0.2% 237

Other funds holding ASAN

VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PharVision Advisers's ASAN Position: Q1 2026 in Review

PharVision Advisers reduced its Asana (ASAN) stake by 62% in Q1 2026, selling an estimated $268K and leaving 18,741 shares worth $120K. The position accounts for 1.22% of the portfolio, ranked #33.

PharVision Advisers first reported a position in ASAN in Q2 2025 and has held it in 4 quarters since. The position peaked at $674K in Q4 2025. 250 funds tracked by Wall St. Rank hold ASAN as of Q1 2026.

  • PharVision Advisers held 18,741 shares of Asana worth $120K as of Q1 2026.
  • PharVision Advisers sold 30,450 Asana shares in Q1 2026, an estimated $268K.
  • Asana made up 1.22% of PharVision Advisers's portfolio in Q1 2026, its #33 holding.
  • PharVision Advisers first reported a position in Asana in Q2 2025 and has held it in 4 quarters since.
  • PharVision Advisers's Asana position peaked at $674K in Q4 2025.
  • 250 funds tracked by Wall St. Rank held Asana as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.